Fut, nem toboroz1. fázis
Phase 1, Randomized, Double-blind, Placebo-Controlled, First-in-Human Single Ascending Dose Study in Healthy Participants to Assess the Safety, Tolerability, and Pharmacokinetics of JNJ-95597528 and a Proof of Mechanism Study in Participants with Mild to Moderate Asthma
Key facts
- Where
- Berlin és Frankfurt am Main, NémetországSee the 2 sites
- Phase
- 1. fázis
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in Németország
- Charite Research Organisation GmbHBerlin, NémetországNo longer taking part
- IKF Pneumologie GmbH & Co. KGFrankfurt am Main, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Janssen Cilag International
- Trial code
- EU 2024-517644-62-00
- Record updated
- 2026. október 16.